IBDEI09S ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4334,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ > 89% Body Surface
 ;;^UTILITY(U,$J,358.3,4334,1,4,0)
 ;;=4^L49.9
 ;;^UTILITY(U,$J,358.3,4334,2)
 ;;=^5009199
 ;;^UTILITY(U,$J,358.3,4335,0)
 ;;=Z65.5^^21^273^26
 ;;^UTILITY(U,$J,358.3,4335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4335,1,3,0)
 ;;=3^Exposure to Disaster/War/Hostilities
 ;;^UTILITY(U,$J,358.3,4335,1,4,0)
 ;;=4^Z65.5
 ;;^UTILITY(U,$J,358.3,4335,2)
 ;;=^5063184
 ;;^UTILITY(U,$J,358.3,4336,0)
 ;;=Z77.22^^21^273^27
 ;;^UTILITY(U,$J,358.3,4336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4336,1,3,0)
 ;;=3^Exposure to/Contact w/ Environmental Tobacco Smoke
 ;;^UTILITY(U,$J,358.3,4336,1,4,0)
 ;;=4^Z77.22
 ;;^UTILITY(U,$J,358.3,4336,2)
 ;;=^5063324
 ;;^UTILITY(U,$J,358.3,4337,0)
 ;;=L30.9^^21^273^5
 ;;^UTILITY(U,$J,358.3,4337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4337,1,3,0)
 ;;=3^Eczema,Unspec
 ;;^UTILITY(U,$J,358.3,4337,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,4337,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,4338,0)
 ;;=L23.9^^21^273^2
 ;;^UTILITY(U,$J,358.3,4338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4338,1,3,0)
 ;;=3^Eczema,Allergic Contact,Unspec
 ;;^UTILITY(U,$J,358.3,4338,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,4338,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,4339,0)
 ;;=L20.82^^21^273^3
 ;;^UTILITY(U,$J,358.3,4339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4339,1,3,0)
 ;;=3^Eczema,Flexural
 ;;^UTILITY(U,$J,358.3,4339,1,4,0)
 ;;=4^L20.82
 ;;^UTILITY(U,$J,358.3,4339,2)
 ;;=^5009109
 ;;^UTILITY(U,$J,358.3,4340,0)
 ;;=L20.84^^21^273^4
 ;;^UTILITY(U,$J,358.3,4340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4340,1,3,0)
 ;;=3^Eczema,Intrinsic
 ;;^UTILITY(U,$J,358.3,4340,1,4,0)
 ;;=4^L20.84
 ;;^UTILITY(U,$J,358.3,4340,2)
 ;;=^5009111
 ;;^UTILITY(U,$J,358.3,4341,0)
 ;;=L51.8^^21^273^10
 ;;^UTILITY(U,$J,358.3,4341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4341,1,3,0)
 ;;=3^Erythema Multiforme,Other
 ;;^UTILITY(U,$J,358.3,4341,1,4,0)
 ;;=4^L51.8
 ;;^UTILITY(U,$J,358.3,4341,2)
 ;;=^336639
 ;;^UTILITY(U,$J,358.3,4342,0)
 ;;=R23.4^^21^273^14
 ;;^UTILITY(U,$J,358.3,4342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4342,1,3,0)
 ;;=3^Eschar/Desquamination of Skin
 ;;^UTILITY(U,$J,358.3,4342,1,4,0)
 ;;=4^R23.4
 ;;^UTILITY(U,$J,358.3,4342,2)
 ;;=^5019296
 ;;^UTILITY(U,$J,358.3,4343,0)
 ;;=L49.9^^21^273^23
 ;;^UTILITY(U,$J,358.3,4343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4343,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 90% or More Body Surface
 ;;^UTILITY(U,$J,358.3,4343,1,4,0)
 ;;=4^L49.9
 ;;^UTILITY(U,$J,358.3,4343,2)
 ;;=^5009199
 ;;^UTILITY(U,$J,358.3,4344,0)
 ;;=L74.9^^21^273^1
 ;;^UTILITY(U,$J,358.3,4344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4344,1,3,0)
 ;;=3^Eccrine Sweat Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,4344,1,4,0)
 ;;=4^L74.9
 ;;^UTILITY(U,$J,358.3,4344,2)
 ;;=^5009296
 ;;^UTILITY(U,$J,358.3,4345,0)
 ;;=L92.3^^21^274^1
 ;;^UTILITY(U,$J,358.3,4345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4345,1,3,0)
 ;;=3^FB Granuloma Skin/Subcutaneous Tissue
 ;;^UTILITY(U,$J,358.3,4345,1,4,0)
 ;;=4^L92.3
 ;;^UTILITY(U,$J,358.3,4345,2)
 ;;=^5009464
 ;;^UTILITY(U,$J,358.3,4346,0)
 ;;=L66.2^^21^274^4
 ;;^UTILITY(U,$J,358.3,4346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4346,1,3,0)
 ;;=3^Folliculitis Decalvans
 ;;^UTILITY(U,$J,358.3,4346,1,4,0)
 ;;=4^L66.2
 ;;^UTILITY(U,$J,358.3,4346,2)
 ;;=^5009254
 ;;^UTILITY(U,$J,358.3,4347,0)
 ;;=L73.9^^21^274^3
 ;;^UTILITY(U,$J,358.3,4347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4347,1,3,0)
 ;;=3^Follicular Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,4347,1,4,0)
 ;;=4^L73.9
